Centiva Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Centiva Capital’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,854	Closed	-$236K	–	2004
2022 Q2	$236K	Buy	23,854 +13,274	+125%	+$131K	0.01%	1219
2022 Q1	$104K	Buy	+10,580	New	+$104K	﹤0.01%	1375
2021 Q3	–	Sell	-28,802	Closed	-$281K	–	1749
2021 Q2	$281K	Buy	28,802 +3,802	+15%	+$37.5K	0.01%	1072
2021 Q1	$249K	Buy	+25,000	New	+$255K	0.01%	885

Other funds holding FLAC

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Centiva Capital's FLAC Position: Q3 2022 in Review

Centiva Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q3 2022, closing a stake of 23,854 shares — an estimated $236K sold.

Centiva Capital first reported a position in FLAC in Q1 2021 and held it in 4 quarters. The position peaked at $281K in Q2 2021. 52 funds tracked by Wall St. Rank hold FLAC as of Q3 2022.

Centiva Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Centiva Capital sold 23,854 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q3 2022, an estimated $236K.
Centiva Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 4 quarters.
Centiva Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $281K in Q2 2021.
52 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.